Schrodinger to offer Eli Lilly's AI drug discovery platform on its software
Reuters·2026-01-09 12:04

Core Insights - Schrodinger is collaborating with Eli Lilly to integrate the pharmaceutical company's AI-based platform, TuneLab, into its drug designing software [1] Company Collaboration - The partnership aims to enhance drug design capabilities by leveraging Eli Lilly's AI technology [1]